These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26517324)

  • 1. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.
    Gordon AJ; Lo-Ciganic WH; Cochran G; Gellad WF; Cathers T; Kelley D; Donohue JM
    J Addict Med; 2015; 9(6):470-7. PubMed ID: 26517324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composition of buprenorphine prescribing networks in Medicaid and association with quality of care.
    Zhu JM; Charlesworth CJ; Stein BD; Drake C; Polsky D; Korthuis PT; McConnell KJ
    J Subst Use Addict Treat; 2024 Aug; 163():209363. PubMed ID: 38641055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
    ; Donohue JM; Jarlenski MP; Kim JY; Tang L; Ahrens K; Allen L; Austin A; Barnes AJ; Burns M; Chang CH; Clark S; Cole E; Crane D; Cunningham P; Idala D; Junker S; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Pauly N; Sheets L; Talbert J; Zivin K; Gordon AJ; Kennedy S
    JAMA; 2021 Jul; 326(2):154-164. PubMed ID: 34255008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
    Samples H; Williams AR; Olfson M; Crystal S
    J Subst Abuse Treat; 2018 Dec; 95():9-17. PubMed ID: 30352671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
    Xu KY; Schiff DM; Jones HE; Martin CE; Kelly JC; Bierut LJ; Carter EB; Grucza RA
    J Gen Intern Med; 2023 Dec; 38(16):3499-3508. PubMed ID: 37436568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
    J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Affordable Care Act In The Heart Of The Opioid Crisis: Evidence From West Virginia.
    Saloner B; Landis R; Stein BD; Barry CL
    Health Aff (Millwood); 2019 Apr; 38(4):633-642. PubMed ID: 30933592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug testing among Medicaid enrollees initiating buprenorphine treatment for opioid use disorder within 9 MODRN states.
    Hammerslag L; Talbert J; Donohue JM; Sharbaugh M; Ahrens K; Allen L; Austin AE; Gordon AJ; Jarlenski M; Kim JY; Mohamoud S; Tang L; Burns M;
    Drug Alcohol Depend; 2023 Sep; 250():110875. PubMed ID: 37413960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
    Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
    JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states.
    ; Cole ES; Allen L; Austin A; Barnes A; Chang CH; Clark S; Crane D; Cunningham P; Fry CE; Gordon AJ; Hammerslag L; Idala D; Kennedy S; Kim JY; Krishnan S; Lanier P; Mahakalanda S; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Tang L; Zivin K; Donohue JM
    Drug Alcohol Depend; 2022 Dec; 241():109670. PubMed ID: 36332591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
    J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.
    Stein BD; Dick AW; Sorbero M; Gordon AJ; Burns RM; Leslie DL; Pacula RL
    Subst Abus; 2018; 39(4):419-425. PubMed ID: 29932847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization.
    Lo-Ciganic WH; Gellad WF; Gordon AJ; Cochran G; Zemaitis MA; Cathers T; Kelley D; Donohue JM
    Addiction; 2016 May; 111(5):892-902. PubMed ID: 26662858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.